Newsroom
Stay informed on our latest company updates, scientific advancements, clinical milestones, and corporate announcements as we continue advancing NLRP3-based medicines.
NodThera to Participate in Cantor Global Healthcare Conference
NLRP3 inhibitor reduces inflammatory biomarkers in high-risk patients
Healio
NodThera Announces the Publication and Presentation of Cardiometabolic Clinical Data Supporting the Potential of Ruvonoflast to Treat Inflammation at the Source
NodThera Announces Late-Breaking Oral Presentation at the 94th EAS Congress
NodThera to Participate in April Investor Conferences
Thera says inflammation drug has positive effect in Parkinson’s
Biopharma Dive